A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma

British Journal of Haematology

Volumn 109, Issue 3, 2000, Pages 661-664

  Moreau, Philippe ^a   Harousseau, Jean Luc ^a   Wijdenes, John ^b   Morineau, Nadine ^a   Milpied, Noël ^a   Bataille, Régis ^a  

^a HÔTEL DIEU   (France)

^b Diaclone   (France)

Author keywords

Anti IL 6 monoclonal antibody; Autologous stem cell transplantation; Conditioning regimen; High dose melphalan; Multiple myeloma

Indexed keywords

BE 8; C REACTIVE PROTEIN; DEXAMETHASONE; INTERLEUKIN 6 ANTIBODY; MELPHALAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BE 8; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTOPENIA;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; MALE; MELPHALAN; MICE; MIDDLE AGED; MULTIPLE MYELOMA; RECURRENCE; TREATMENT OUTCOME;

EID: 0034046108     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02093.x     Document Type: Article

References (12)

1. Adam, A., Ers, P., Herman, G., & Stas, J.L. (1985) Analytical evaluation of a new latex agglutination test for quantitative determination of C-reactive protein by laser nephelometry. Journal of Clinical Chemistry and Clinical Biochemistry, 23, 787-791.
2. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Thyss, H., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. New England Journal of Medicine, 335, 91-97.
3. Bataille, R., Barlogie, B., Lu, Z.Y., Rossi, J.F., Lavabre-Bertrand, T., Beck, T., Wijdenes, J., Brochier, J. & Klein, B. (1995) Biological effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood, 86, 685-691.
4. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H. & Epstein, J. (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood, 84, 3063-3068.
5. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
6. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, J., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) A paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
7. Klein, B., Wijdenes, J., Zhang, X.G., Jourdan, M., Boiron, J., Brochier, J., Liautard, J., Merlin, M., Clément, C., Morel-Fournier, B., Lu, Z., Mannoni, P., Sany, J. & Bataille, R. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood, 78, 1198-1204.
8. Mehta, J., Tricot, G., Jagannath, S., Ayers, D., Singhal, S., Siegel, D., Desikan, K., Munshi, N., Fassas, A., Mattox, S., Vesole, D., Crowley, J. & Barlogie, B. (1998) Salvage autologous or allogeneic transplantation for multiple myeloma. Bone Marrow Transplantation, 21, 887-892.
9. 2 melphalan followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma. Bone Marrow Transplantation, 23, 1003-1006.
10. Samuels, B.J. & Bitran, J.D. (1995) High-dose intravenous melphalan: a review. Journal of Clinical Oncology, 13, 1786-1799.
11. Vesole, D.H., Barlogie, B., Jagannath, S., Cheson, B., Tricot, G., Alexanian, R. & Crowley, J. (1994) High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood, 84, 950-956.
12. van Zaanen, H.C.T., Koopmans, R.P., Aarden, L.A., Rensink, H.J.A.M., Stouthard, J.M.L., Warnaar, S.O., Lokhorst, H.M. & van Oers, M.H.J. (1996) Endogenous interleukin-6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL-6 antibodies indicates the existence of a positive feed-back loop. Journal of Clinical Investigations, 98, 1441-1448.